Content (164)
-
People NewsKGAL announces new dual leadership team and forward-looking corporate strategy
Leading independent investment and asset manager KGAL is pleased to announce that it has completed its “Next Generation” project through a new management structure and reorganisation of its Real Estate, Sustainable Infrastructure and Aviation asset classes, and Florian Martin, currently Managing Director Capital, and André Zücker, currently Managing Director Real Estate, will take over the company management together as co-CEOs as of 1 January 2024.
-
Asset Manager NewsKGAL acquires “Treesquare” office building in prime Brussels location
KGAL Investment Management has acquired the “Treesquare” office block in Brussels for its pan-European real estate fund, KGAL Core 4 Real Estate.
-
Asset Manager NewsKGAL sells office building in London to Obayashi
KGAL Investment Management has sold the office building “60 Gracechurch Street”, with a total lettable space of 11,825 square metres, from one of its closed-end funds.
-
Asset Manager NewsKGAL sums up 2022 – a year of surging interest rates and exceptional performance
KGAL, a leading independent investment and asset manager, sums up its performance in 2022 and despite inflation, interest rate turnaround, energy crisis – KGAL passed the tests of 2022 with flying colours. New business volume reached almost €1.9 billion across all asset classes.
-
Asset Manager NewsNew impact fund KGAL Core 5 LIFE reaches first closing and acquires sustainable residential property in Málaga
KGAL Core 5 LIFE, one of the few Article 9 residential real estate funds with a European focus, has received capital commitments in the hundreds of millions.
-
Asset Manager NewsKGAL ́s neighbourhood quarter “Perlach Plaza” in Munich gets off to a flying start
In August 2020, KGAL Investment Management acquired “Perlach Plaza” as a forward deal from project developers CONCRETE and BHB Bauträger GmbH Bayern, for a total investment cost of around EUR 250 million on behalf of three institutional investors.
-
People NewsKGAL appoints Britta Roden as Head of Research
Grünwald, 10.01.2023 – KGAL Group is pleased to announce the appointment of Britta Roden MRICS as Head of Research as of 1 January 2023.
-
Asset Manager NewsKGAL fund sells residential complex in Brühl near Cologne
Grünwald, 07/09/2022 - The KGAL Wohnen Core 2 fund, managed by KGAL GmbH & Co. KG, has sold a residential complex with 254 rental units in Brühl near Cologne, to Domicil Real Estate AG.
-
People NewsKGAL appoints new Head of Open Investment Funds
Leading independent investment and asset manager KGAL today announces the appointment of Michael Kohl as its new Head of Open Investment Funds.
-
Asset Manager NewsKGAL acquires fully-let property in the heart of Rotterdam
Grünwald, 22/08/2022 - KGAL Investment Management GmbH & Co. KG has acquired the fully-leased 9,200 sqm office property Westerlaan 10 (W10) on behalf of a pan-European fund. The property, which is located in the city centre and has a high-quality interior, has been the corporate headquarters of Vopak for many years. The internationally active, listed group extended its lease for 15 years in 2020.
-
Asset Manager NewsKGAL sells Deutsche Telekom’s global headquarters on behalf of South Korean institutional investors
Grünwald, 20/07/2022 – KGAL GmbH & Co. KG successfully sold Deutsche Telekom’s 81,000 sqm (approximately) global headquarters, located in Bonn. The company acted both as part owner of the property and as transaction advisor to the majority owners, several South Korean institutional investors. The modern headquarters in Bonn’s federal ...
-
White papersLife Science in Germany
It is now time to provide a detailed analysis of the real estate sector for life sciences companies. This market segment is attracting everincreasing interest from property developers, investors and financiers. It comes as no surprise that medical technology, pharmaceuticals and biotech companies have gained significant prominence over the last two years in view of their huge contribution to the control of the Covid-19 pandemic.
